Triaminic Vapor Patch

Triaminic Vapor Patch is a topical cough suppressant product formerly marketed by Novartis Consumer Health. It is a medicated adhesive patch containing a combination of camphor (4.7%), menthol (2.6%), and eucalyptus oil, designed for use in children aged 2 years and older. When applied to the chest or throat, the patch releases aromatic vapors that are inhaled by the patient to provide symptomatic relief from coughing for up to 8 hours. Unlike systemic cough suppressants, it works through local sensory effects and inhalation rather than a specific molecular biological target. The product was introduced in 2000 but was subject to a nationwide voluntary recall in 2006 following reports of serious adverse events, including seizures, associated with accidental ingestion by children who removed and chewed on the patches.

Brand names

Triaminic Vapor Patch